HaoNguyenMDPhD

Urology • San Francisco, CA

Minimally Invasive Surgery, Surgical Oncology

Associate Professor, UCSF School of Medicine Richard and Lelani Grinold endowed professor

Join to view full profile

Dr. Nguyen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Nguyen's full profile

Already have an account?

Office
1825 4th Street, 4th Floor
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, CA 94158
Phone+1 415-353-7100

Education & Training

University of California (San Francisco)Fellowship, Minimally Invasive Urologic Surgery, 2013 - 2015
University of California Davis HealthResidency, Urology, 2009 - 2013
University of California Davis HealthResidency, Surgery, 2007 - 2009
Boston University School of MedicineClass of 2007

Certifications & Licensure

CA State Medical License 2008 - 2026
American Board of Urology Urology

Clinical Trials

Trial of Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate Cancer Start of enrollment: 2015 Dec 22
Terminated
Phase 2

Publications & Presentations

PubMed

Targeted Biopsy Is Sufficient for Men on Active Surveillance for Early-Stage Prostate Cancer.
Mary O Fakunle, Janet E Cowan, Samuel L Washington 3rd, Katsuto Shinohara, Hao G Nguyen
The Journal of Urology. 2025-01-01
2 citations
The state of focal therapy in the treatment of prostate cancer: the university of California collaborative (UC-Squared) consensus statement.
Juan Javier-DesLoges, Marc A Dall'Era, Wayne Brisbane, Karim Chamie, Samuel L Washington 3rd
Prostate Cancer and Prostatic Diseases. 2024-12-01
Determining Long-term Prostate Cancer Outcomes for Active Surveillance Patients Without Early Disease Progression: Implications for Slowing or Stopping Surveillance.
Kevin Shee, James Nie, Janet E Cowan, Lufan Wang, Samuel L Washington 3rd
European Urology Oncology. 2024-09-27

Journal Articles

First-in-Human Phase I Study of CTT1057, a Novel 18F Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate Specific Membrane Antigen in Prostate Cancer
Spencer C Behr, Hao G Nguyen, Thomas A Hope, Kirsten L Greene, Matthew R Cooperberg, Robert R Flavell, Eric J Small, Peter R Carroll, Journal of Nuclear Medicine

Press Mentions

Drug ISRIB Is a Memory Enhancer, Anti Cancer Agent, Protects Hearing and Perhaps Has Anti Aging EffectsDecember 27th, 2020
Research Finds ‘Achilles Heel’ for Aggressive Prostate CancerMay 14th, 2018
Experimental Treatment Is 'Achilles Heel' for Aggressive Prostate TumorsMay 3rd, 2018
Join now to see all